Navigation Links
Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
Date:9/22/2008

Approximately $20 Million of New Business Contracts Announced During the

Past Ten Weeks

WAYNE, Penn., Sept. 22 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO), a full-service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, today announced the signing of $6.2 million of new business contracts, primarily consisting of vaccine clinical trials with a major global biopharmaceutical company to be conducted in multiple European countries. Revenue recognition will begin in the fourth quarter of 2008 with the remainder expected to occur on a proportional basis as services are performed on each project.

David Ginsberg, DO, Encorium Group's new President and Chief Executive Officer, stated, "We are delighted to have become a significant partner to this global pharmaceutical company in their vaccines development. Encorium is currently a leading CRO, when it comes to the experience and expertise in the clinical development of pediatric vaccines. I am very proud of our excellent people, who are the key to this kind of repeat business. Vaccine development will continue to be key area of focus for Encorium in the future."

Kai Lindevall, M.D., Ph.D., Encorium's Executive Chairman, commented, "We are very encouraged by the volume of new contracts we have been able to sign during the last 10 weeks. Most of these wins relate to our European operations, but we are currently strengthening our business development efforts in the U.S. and expect to achieve results from this effort early next year. We will continue to strengthen our ca
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
5. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
6. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
7. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
8. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
11. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ... the "Urinary Catheters Market (Indwelling or Foley Catheters, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... , At present, the global market for ...
(Date:1/23/2015)... 2015 More than a third of reproductive-aged women enrolled ... private insurance, filled a prescription for an opioid pain medication ... week,s Morbidity and Mortality Weekly Report (MMWR). ... moderate to severe pain.  They are also found in some ...
(Date:1/23/2015)...  Now available for sale, The Armor1 Ankle Roll Guard is ... sprains by cushioning the ankle from an inversion or ... outside of any shoe type and allows the user ... protection against sprains. With customers in physical therapy, podiatry, ...
Breaking Medicine Technology:Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... Oct. 1 A web-based tool that extracts information from ... care and manage their entire panel of patients. Those are ... first to examine the effectiveness of a panel management tool ... first study, published today in The American Journal of ...
... U.S. Centers for Disease Control and Prevention officials ... the past two years, bringing the total number of ... comes almost 10 years to the date after the ... deeming it a major advancement for women,s health and ...
Cached Medicine Technology:Innovative Web-based Tool Helps Doctors Improve Care 2Innovative Web-based Tool Helps Doctors Improve Care 3Innovative Web-based Tool Helps Doctors Improve Care 4Innovative Web-based Tool Helps Doctors Improve Care 5FRC's Jeanne Monahan Responds to Two New Deaths from RU-486 2
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz ... has treated just about every type of injury that can result ... those same twenty-plus years, the team at Doctors on Liens ... best possible doctor. With the combined breadth of experience ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... January 22, 2015 Yesterday, Senator ... (D-Concord) and Kristin Olsen (R-Modesto) were honored by ... in advancing biotechnology, biomedical science, medical device and ... each received the “2014 Life Sciences Champion” award ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... LLC, a,Johnson & Johnson company, is pleased to announce ... (BLN) Assay one of the top ten,medical breakthroughs of ... magazine, available today, TIME,states: "Surgeons now have a faster ... BLN Assay, TIME goes on to say, "doctors can,accurately ...
... Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a ... Pharmaceuticals, Inc., a wholly owned,subsidiary of Barr ... Watson and certain of its subsidiaries related ... version of,Seasonale(R), an extended cycle oral contraceptive. ...
... Cross and Pitney Bowes Program Bolstered by Celebrity ... members are always grateful for supportive cards, especially ... been pouring in to the,American Red Cross for ... singer Randy Travis and his wife, Elizabeth, heard,about ...
... 2008, Wyeth (NYSE: WYE ) will announce financial ... Company will hold a one-hour conference,call with research analysts ... Company also plans to discuss financial guidance for 2008 ... listen to the call live or on a,delayed basis ...
... Writers Webinar , NCI and ASCO will host an ... that will explore key issues surrounding cancer in the ... the United States, Africa, Asia and India will address ... and Mortality Trends , The State of Cancer ...
... Neurochem,(International) Limited (Neurochem), a wholly-owned subsidiary of ... announces that the Committee for Medicinal,Products for ... the European,Medicines Agency (EMEA), has issued a ... application (MAA) for eprodisate,(KIACTA(TM)) for the treatment ...
Cached Medicine News:Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 2Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 3Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 4Health News:Watson Confirms Patent Litigation With Barr Related to Seasonale(R) 2Health News:Randy Travis Participates in American Red Cross Holiday Card Program to Wounded Service Members 2Health News:Randy Travis Participates in American Red Cross Holiday Card Program to Wounded Service Members 3Health News:NCI/ASCO host science writers' seminar 2Health News:Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis 2Health News:Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis 3
... ADVIA Centaur delivers a ... It provides the flexibility to ... system, now and in the ... a comprehensive disease-focused menu of ...
... assay method for the semi-quantitative determination ... in human serum. The results of ... as an aid in the diagnosis ... associated with elevated anti-neutrophil cytoplasmic antibodies ...
... Inc. (DAI) Myeloperoxidase (MPO) Enzyme-Linked Immunosorbent ... and semi-quantitative determination of IgG, A, M ... assay is used to detect antibodies ... of the assay are to be used ...
Anti-RSV IgA Assay (ELISA)....
Medicine Products: